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METABOLITES OF BENZO (A)
PYRENE (BP) WHICH BIND TO DNA.
H. W. S. KING, K. ALEXANDROV, M. R.
OSBORNE, M. H. THOMPSON and P. BROOKES,
Pollards Wood Research Station, Bucks.
The binding of metabolites of BP to
added native or denatured DNA catalysed by
rat liver microsomes, and to endogenous DNA
catalysed by rat liver nuclei, was studied by
hydrolysis of the isolated DNA and column
chromatography on LH20 Sephadex. The
same 2 major deoxyribonucleoside-hydro-
carbon products were obtained from micro-
somes and from nuclei. That which eluted
first was indistinguishable from the single
product obtained from mouse embryo cells
exposed in culture to BP, and from the single
product obtained when microsomes metabol-
ized BP-7, 8-dihydrodiol, or, to a much lesser
extent, BP-4,5-diol. Formation of this
product by microsomes from BP was pre-
vented by inhibitors of epoxide hydrase such
as TCPO. The second product which eluted
from the column was not observed in mouse
embryo cells. Its formation was not pre-
vented by TCPO. It was also observed when
BP-9, 10-diol was added to microsomes.
THE DETECTION OF ACTIVATED
CARCINOGENS WITH BACTERIO-
PHAGE A. S. M. ToOGOOD and R. C.
GARNER, Department of Experimental Path-
ology and Cancer Research, University of
Leeds.
Use has been made of inactivation and
clear plaque mutation of bacteriophage A to
study some activated carcinogens. Phage
inactivation was found after incubation with
a direct-acting carcinogen, 7-bromomethyl-
benz(a)anthracene and also after incubation
with liver mixed function oxidase enzymes
and aflatoxin B1, a carcinogen requiring
metabolic activation. In the latter case
ultraviolet reactivation of the phage by the
host bacterium was also demonstrated. This
mutational assay may have certain advan-
tages over bacterial tests in that clearplaque
mutagenesis is a forward mutation assay
which detects agents causing frameshift,
base-pair substitution or deletion mutations.
In addition, the slow inactivation' of this
phage in animals makes it suitable for in vivo
mutation studies. Viable plaque particles
have been recovered in the liver, lung, kidney
and spleen up to 24 h after intraperitoneal
phage administration. It is hoped that this
can be used to measure organ-specific
activation of carcinogens.
METABOLIC N-OXIDATION AND THE
pKa CONCEPT. J. W. GORROD, Chelsea
College, London.
The metabolic oxidation of nitrogen
occurring in organic molecules can be
achieved in vitro with a hepatic microsomal
fraction fortified with NADPH in the
presence of molecular oxygen. Two enzyme
systems are known which can carry out this
process, one utilizes a flavoprotein whilst the
other is mediated via an electron transport
chain terminating in cytochrome P-450.
A concept has been developed (Gorrod,
Chem-Biol. Interactions, 1973, 7, 289) which
differentiates these processes depending upon
the pKa of the substrate N-oxidized. Basic
amines are oxidized by the flavoprotein
system, non-basic nitrogen employs the
cytochrome-P450 system and aromatic
amines are probably substrates for both
systems. The actual system utilized depends
upon the pKa of the substrc,te, the relative
affinities towards the enzymes and the ratio of
enzyme within a tissue.
It is suggested that this concept may be
useful in deciding the correct animal species




COLONIC MUCOSA AND CHEMIC-
ALLY INDUCED RAT COLONIC TU-
MOURS. N. MIAN and C. A. NUTMAN,
Department of Experimental Pathology and
Cancer Research, University of Leeds.
Isozymes of f3-N-acetylglucosaminidase
(EC 3.2.1.30) and off3-N-acetylgalactosamini-
dase (EC 3.2.1.53) from 1, 2-dimethylhydra-
zine induced rat colonic tumours and from the
mucosa of control and tumour bearing
animals were separated on polyacrylamide
gel electrophoresis. There was no electro-
phoretic differences between the isozymes of
the two 3-N-acetylhexosaminidases.
Colonic mucosa from normal and tumour
bearing animals contained a fast anodic and
preponderant isozyme A, a slow and weak
isozyme B and an intermediate isozyme C.
On the contrary, in colonic tumours isozyme
C was absent and the activity of isozyme AABSTRACTS OF MEMBERS PAPERS 253
was markedly reduced compared with
isozyme A of normal mucosa. Heating of
enzyme extracts at 50°C for 30 min before
electrophoresis caused no change in the
electrophoretic mobilities of any of the
isozymes but slightly reduced their staining
intensities. On the other hand, after heating
at 55°C for 30 min, isozymes A and C were
hardly detectable on subsequent staining.
Incubation of enzyme extracts with neura-
minidase at 37°C for 18 h caused no signi-
ficant changes either in the mobility or in the
staining reaction of any of these isozymes
from normal and experimental tissuse.
Isozymes A and C appeared to be soluble
enzymes whereas isozyme B, due to its
extraction in 0.2% Triton X-100, seemed to
be bound to lysosomes.
IS ALKYLATION OF NICOTINAMIDE
THE CAUSE OF LIVER NECROSIS
THAT FOLLOWS LARGE DOSES OF
HEPATOCARCINOGENS? R. SCHOEN-
TAL, Department of Pathology, Royal
Veterinary College, London.
Large doses of hepatocarcinogens cause
liver necrosis, not seen after doses which can
induce tumours. In the course of their
metabolism, many hepatocarcinogens yield
alkylating entities, known to alkylate nucleic
acids, proteins and other cell constituents,
including nicotinamide (Schein etal., Biochem.
Pharmac., 1973, 22, 2625; Chu and Lawley,
Chem. Biol. Interactions, 1974, 8, 65).
Alkylated derivatives of nicotinamide cannot
be utilized for the biosynthesis of NAD
cofactors, essential for cell survival. Deple-
tion ofNAD in the liver occurs after pyrrolizi-
dine alkaloids, dimethylnitrosamine, strepto-
zotocin etc., and can be prevented by
pretreatment with nicotinamide, which in
some cases prevents also the cytotoxic
effects.
More information is needed as regards the
role of alkylated derivatives of nicotinamide
in cell death and in relation to tumour
induction.
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CHEMICAL BASIS FOR THE
RELATIONSHIP BETWEEN MUTA-
GENESIS AND CARCINOGENESIS.
P. BROOKES, Pollards Wood Research
Station, Bucks.
A relationship between carcinogenesis and
mutagenesis was first suggested by T. Boveri
in 1917 and K. H. Bauer in 1928 proposed the
somatic mutation theory of cancer, although
at that time the nature ofthe genetic material
was unknown. The recognition of the
biological role of DNA, following the elucid-
ation of its structure by Crick and Watson in
1953, did not immediately revive the support
for the mutation theory of cancer which had
been under strong attack. This was mainly
the result of the repeated failure to demon-
strate mutation with such classic carcinogens
as the polycyclic hydrocarbons and aromatic
amines. Prior to 1940 polycyclic hydro-
carbons were almost the only well studied
group ofcarcinogens. During the subsequent
20 years, however, the number and variety of
chemical substances both synthetic and
naturally occurring, which were shown to
induce cancer in animals, became so great
that it seemed impossible to conceive of any
common mechanism of tumour induction.
The breakthrough came with the recog-
nition of the importance of metabolism in
converting the applied carcinogen to the
biologically active form. One class of car-
cinogen, namely the biological alkylating
agents, did not require metabolic activation
and a study oftheir mechanism of action had
implicated DNA reaction. It seemed
possible therefore that all carcinogens might
act via electrophilic intermediates similar to
those involved in alkylation and that these
" ultimate carcinogens" might modify
cellular DNA.
A great deal of evidence is now available
which supports both the above postulates.
In the case of the aromatic amines the
identification of N-hydroxy metabolites by
the Millers led to an understanding of